<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "4: Companys ", fill: "#efcc00"},
{source: "4: Companys ", target: "4: expectations", fill: "#efcc00"},
{source: "4: expectations", target: "4: operations performance", fill: "#efcc00"},
{source: "4: operations performance", target: "4: achievements", fill: "#efcc00"},
{source: "4: Companys ", target: "9: risks uncertainties", fill: "#efbbcc"},
{source: "9: risks uncertainties", target: "9: without limitation", fill: "#efbbcc"},
{source: "9: without limitation", target: "9: decision by", fill: "#efbbcc"},
{source: "9: decision by", target: "9: supply agreement", fill: "#efbbcc"},
{source: "9: supply agreement", target: "9: Companys ", fill: "#efbbcc"},
{source: "9: Companys ", target: "9: dependence on", fill: "#efbbcc"},
{source: "9: dependence on", target: "9: key customers uncertain demand", fill: "#efbbcc"},
{source: "9: key customers uncertain demand", target: "9: acceptance", fill: "#efbbcc"},
{source: "9: acceptance", target: "9: Companys ", fill: "#efbbcc"},
{source: "9: Companys ", target: "9: nanocrystalline materials", fill: "#efbbcc"},
{source: "9: nanocrystalline materials", target: "9: Companys ", fill: "#efbbcc"},
{source: "9: Companys ", target: "9: manufacturing capacity", fill: "#efbbcc"},
{source: "9: manufacturing capacity", target: "9: product mix flexibility", fill: "#efbbcc"},
{source: "9: product mix flexibility", target: "9: customer demand", fill: "#efbbcc"},
{source: "9: customer demand", target: "9: Companys ", fill: "#efbbcc"},
{source: "9: Companys ", target: "9: development", fill: "#efbbcc"},
{source: "9: development", target: "9: distribution", fill: "#efbbcc"},
{source: "9: distribution", target: "9: relationships", fill: "#efbbcc"},
{source: "9: relationships", target: "9: competitive products", fill: "#efbbcc"},
{source: "9: competitive products", target: "9: technologies", fill: "#efbbcc"},
{source: "9: technologies", target: "9: Companys ", fill: "#efbbcc"},
{source: "9: Companys ", target: "9: dependence on patents", fill: "#efbbcc"},
{source: "9: dependence on patents", target: "9: proprietary", fill: "#efbbcc"},
{source: "9: proprietary", target: "9: litigation", fill: "#efbbcc"},
{source: "9: litigation", target: "9: may become involved", fill: "#efbbcc"},
{source: "9: may become involved", target: "9: risks set forth under", fill: "#efbbcc"},
{source: "9: risks set forth under", target: "9: Risk Factors ", fill: "#efbbcc"},
{source: "9: risks uncertainties", target: "23: difficulties", fill: "#fdee00"},
{source: "23: difficulties", target: "23: encountered", fill: "#fdee00"},
{source: "23: encountered", target: "23: by early stage companies", fill: "#fdee00"},
{source: "23: by early stage companies", target: "23: evolving markets", fill: "#fdee00"},
{source: "23: difficulties", target: "47: difficult", fill: "#43b3ae"},
{source: "47: difficult", target: "47: accurately", fill: "#43b3ae"},
{source: "47: accurately", target: "47: additional", fill: "#43b3ae"},
{source: "47: additional", target: "47: materialize", fill: "#43b3ae"},
{source: "47: difficult", target: "52: conditions often", fill: "#bb6528"},
{source: "52: conditions often", target: "52: connection with", fill: "#bb6528"},
{source: "52: connection with", target: "52: anticipation", fill: "#bb6528"},
{source: "52: anticipation", target: "52: general economic conditions", fill: "#bb6528"},
{source: "52: conditions often", target: "63: sustain such collaborative relationships", fill: "#fba0e3"},
{source: "63: sustain such collaborative relationships", target: "63: relationships limit", fill: "#fba0e3"},
{source: "63: relationships limit", target: "63: distribution", fill: "#fba0e3"},
{source: "63: distribution", target: "63: strategic partners", fill: "#fba0e3"},
{source: "63: strategic partners", target: "63: products efficiently", fill: "#fba0e3"},
{source: "63: products efficiently", target: "63: independently", fill: "#fba0e3"},
{source: "63: independently", target: "63: manufacture", fill: "#fba0e3"},
{source: "63: manufacture", target: "63: future nanocrystalline materials", fill: "#fba0e3"},
{source: "63: future nanocrystalline materials", target: "63: applications", fill: "#fba0e3"},
{source: "63: sustain such collaborative relationships", target: "70: agreements", fill: "#c3b091"},
{source: "70: agreements", target: "70: technology", fill: "#c3b091"},
{source: "70: technology", target: "70: development", fill: "#c3b091"},
{source: "70: development", target: "70: activities", fill: "#c3b091"},
{source: "70: agreements", target: "182: agreement", fill: "#2f4f4f"},
{source: "182: agreement", target: "182: certificate", fill: "#2f4f4f"},
{source: "182: certificate", target: "182: Delaware ", fill: "#2f4f4f"},
{source: "182: Delaware ", target: "182: separately", fill: "#2f4f4f"},
{source: "182: separately", target: "182: discourage potential acquisition proposals", fill: "#2f4f4f"},
{source: "182: discourage potential acquisition proposals", target: "182: investors might", fill: "#2f4f4f"},
{source: "182: investors might", target: "182: common stock", fill: "#2f4f4f"},
{source: "182: agreement", target: "START_HERE", fill: "#2f4f4f"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Diversified Financial Services</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Economic</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Policy</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Demonstrate</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Riot</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Natural disaster</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Lluís_Companys">Lluís Companys</a></td>
      <td>Lluís Companys i Jover (Catalan pronunciation: [ʎuˈis kumˈpaɲs]; 21 June 1882 – 15 October 1940) was a Spanish politician from Catalonia who served as president of Catalonia from 1934 and during the Spanish Civil War.\nCompanys was a lawyer close to labour movement and one of the most prominent leaders of the Republican Left of Catalonia (ERC) political party, founded in 1931.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Passeig_de_Lluís_Companys,_Barcelona">Passeig de Lluís Companys, Barcelona</a></td>
      <td>Passeig de Lluís Companys (Catalan pronunciation: [pəˈsɛdʒ də ʎuˈis kumˈpaɲs]) is a promenade in the Ciutat Vella and Eixample districts of Barcelona, Catalonia, Spain, and can be seen as an extension of Passeig de Sant Joan. It was named after President Lluís Companys, who was executed in 1940.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Estadi_Olímpic_Lluís_Companys">Estadi Olímpic Lluís Companys</a></td>
      <td>Estadi Olímpic Lluís Companys (Catalan pronunciation: [əsˈtaði uˈlimpiɡ ʎuˈis kumˈpaɲs], formerly known as the Estadi Olímpic de Montjuïc and Estadio de Montjuic) is a stadium in Barcelona, Catalonia, Spain. Originally built in 1927 for the 1929 International Exposition in the city (and Barcelona's bid for the 1936 Summer Olympics, which were awarded to Berlin), it was renovated in 1989 to be the main stadium for the 1992 Summer Olympics and 1992 Summer Paralympics.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Company">Company</a></td>
      <td>A company, abbreviated as co., is a legal entity representing an association of people, whether natural, legal or a mixture of both, with a specific objective. Company members share a common purpose and unite to achieve specific, declared goals.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Companys,_procés_a_Catalunya">Companys, procés a Catalunya</a></td>
      <td>Companys, procés a Catalunya (Spanish: Companys, proceso a Cataluña) is a 1979 Spanish Catalan drama film directed by Josep Maria Forn, based on the last months of the life of the President of Catalonia, Lluís Companys, in which he shows his detention by the Nazis and his subsequent execution by the Spanish Francoists. It competed in the Un Certain Regard section at the 1979 Cannes Film Festival.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Holding_company">Holding company</a></td>
      <td>A holding company is a company whose primary business is holding a controlling interest in the securities of other companies. A holding company usually does not produce goods or services itself.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Conxita_Julià">Conxita Julià</a></td>
      <td>Conxita Julià i Farrés (Catalan pronunciation: [kuɲˈʃitə ʒuliˈa j fəˈres]; 11 June 1920 – 9 January 2019), also known as Conxita de Carrasco, was a Catalan woman noted for her dealings with Lluís Companys, President of Catalonia, in the 1930s, and for her poetry. Julià died in January 2019 at the age of 98.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_largest_companies_in_the_United_States_by_revenue">List of largest companies in the United States by revenue</a></td>
      <td>This list comprises the largest companies in the United States by revenue as of 2022, according to the Fortune 500 tally of companies. Retail corporation Walmart has been the largest company in the US by revenue since 2014.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Amazon_(company)">Amazon (company)</a></td>
      <td>Amazon.com, Inc. ( AM-ə-zon) is an American multinational technology company which focuses on e-commerce, cloud computing, digital streaming, and artificial intelligence.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/El_Tarròs">El Tarròs</a></td>
      <td>El Tarròs (Spanish: Tarrós) is a small village in Tornabous municipality, in the province of Lleida, in Catalonia, Spain. In 2008 it had 100 inhabitants.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Manufacturing">Manufacturing</a></td>
      <td>Manufacturing is the creation or production of goods with the help of equipment, labor, machines, tools, and chemical or biological processing or formulation. It is the essence of secondary sector of the economy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Technology">Technology</a></td>
      <td>Technology is the result of accumulated knowledge and application of skills, methods, and processes used in industrial production and scientific research. Technology is embedded in the operation of all machines, with or without detailed knowledge of their function, for the intended purpose of an organization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Information_technology">Information technology</a></td>
      <td>Information technology (IT) is the use of computers to create, process, store, retrieve, and exchange all kinds of electronic data and information. IT is typically used within the context of business operations as opposed to personal or entertainment technologies.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Healing_Is_Difficult">Healing Is Difficult</a></td>
      <td>Healing Is Difficult is the second studio album by Australian singer and songwriter Sia. It was released in the United Kingdom on 9 July 2001 and in the United States on 28 May 2002.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Difficult_Loves">Difficult Loves</a></td>
      <td>Difficult Loves (Italian: Gli amori difficili) is a 1970 short story collection by Italo Calvino. It concerns love and the difficulty of communication.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/A_Difficult_Woman">A Difficult Woman</a></td>
      <td>A Difficult Woman is an Australian television series which screened in 1998 on the ABC. The three part series starred Caroline Goodall, in the title role of a woman whose best friend is murdered and is determined to find out why. It was written by Nicholas Hammond and Steven Vidler and directed by Tony Tilse.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Second-language_acquisition">Second-language acquisition</a></td>
      <td>Second-language acquisition (SLA), sometimes called second-language learning — otherwise referred to as L2 (language 2) acquisition, is the process by which people learn a second language. Second-language acquisition is also the scientific discipline devoted to studying that process.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Difficult_Couple">The Difficult Couple</a></td>
      <td>The Difficult Couple (Chinese: 难夫难妻; pinyin: Nànfū Nànqī), also translated as Die for Marriage, is a 1913 Chinese film. It is known for being the earliest Chinese feature film.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Globe_Sessions">The Globe Sessions</a></td>
      <td>The Globe Sessions is the third studio album by American singer-songwriter Sheryl Crow, released on September 21, 1998, in the United Kingdom and September 29, 1998, in the United States, then re-released in 1999. It was nominated for Album of the Year, Best Rock Album and Best Engineered Non-Classical Album at the 1999 Grammys, winning the latter two awards.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Stock_market">Stock market</a></td>
      <td>A stock market, equity market, or share market is the aggregation of buyers and sellers of stocks (also called shares), which represent ownership claims on businesses; these may include securities listed on a public stock exchange, as well as stock that is only traded privately, such as shares of private companies which are sold to investors through equity crowdfunding platforms. Investment is usually made with an investment strategy in mind.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Automotive_industry">Automotive industry</a></td>
      <td>The automotive industry comprises a wide range of companies and organizations involved in the design, development, manufacturing, marketing, and selling of motor vehicles. It is one of the world's largest industries by revenue (from 16 % such as in France up to 40 % to countries like Slovakia).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Technology_company">Technology company</a></td>
      <td>A technology company (or tech company) is an electronics-based technological company, including, for example, business relating to digital electronics, software, and internet-related services, such as e-commerce services.\n\n\n== Details ==\nAccording to Fortune, as of 2020, the ten largest technology companies by revenue are: Apple Inc., Samsung, Foxconn, Alphabet Inc., Microsoft, Huawei, Dell Technologies, Hitachi, IBM, and Sony.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_technology">Financial technology</a></td>
      <td>Financial technology (abbreviated fintech or FinTech) is the technology and innovation that aims to compete with traditional financial methods in the delivery of financial services. Artificial intelligence, Blockchain, Cloud computing, and big Data are regarded as the "ABCD" (four key areas) of FinTech.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Language_technology">Language technology</a></td>
      <td>Language technology, often called human language technology (HLT), studies methods of how computer programs or electronic devices can analyze, produce, modify or respond to human texts and speech. Working with language technology often requires broad knowledge not only about linguistics but also about computer science.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Space_technology">Space technology</a></td>
      <td>Space technology is technology for use in outer space, in travel (astronautics) or other activities beyond Earth's atmosphere, for purposes such as spaceflight, space exploration, and Earth observation. Space technology includes space vehicles such as spacecraft, satellites, space stations and orbital launch vehicles; deep-space communication; in-space propulsion; and a wide variety of other technologies including support infrastructure equipment, and procedures.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Information_technology_consulting">Information technology consulting</a></td>
      <td>In management, information technology consulting (also called IT consulting, computer consultancy, business and technology services, computing consultancy, technology consulting, and IT advisory) is a field of activity which focuses on advising organizations on how best to use information technology (IT) in achieving their business objectives.\nOnce a business owner defines the needs to take a business to the next level, a decision maker will define a scope, cost and a time frame of the project.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bachelor_of_Technology">Bachelor of Technology</a></td>
      <td>A Bachelor of Technology (Latin Baccalaureus Technologiae, commonly abbreviated as B.Tech. or BTech; with honours as B.Tech.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Common_stock">Common stock</a></td>
      <td>Common stock is a form of corporate equity ownership, a type of security. The terms voting share and ordinary share are also used frequently outside of the United States.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Common_stock_dividend">Common stock dividend</a></td>
      <td>A common stock dividend is the dividend paid to common stock owners from the profits of the company.  Like other dividends, the payout is in the form of either cash or stock.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Preferred_stock">Preferred stock</a></td>
      <td>Preferred stock (also called preferred shares, preference shares, or simply preferreds) is a component of share capital that may have any combination of features not possessed by common stock, including properties of both an equity and a debt instrument, and is generally considered a hybrid instrument. Preferred stocks are senior (i.e., higher ranking) to common stock but subordinate to bonds in terms of claim (or rights to their share of the assets of the company, given that such assets are payable to the returnee stock bond) and may have priority over common stock (ordinary shares) in the payment of dividends and upon liquidation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Matthiola_incana">Matthiola incana</a></td>
      <td>Matthiola incana is a species of flowering plant in the cabbage family Brassicaceae. Common names include Brompton stock, common stock, hoary stock, ten-week stock, and gilly-flower.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Consolidation_(business)">Consolidation (business)</a></td>
      <td>In business, consolidation or amalgamation is the merger and acquisition of many smaller companies into a few much larger ones. In the context of financial accounting, consolidation refers to the aggregation of financial statements of a group company as consolidated financial statements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/New_York_Stock_Exchange">New York Stock Exchange</a></td>
      <td>The New York Stock Exchange (NYSE, nicknamed "The Big Board") is an American stock exchange in the Financial District of Lower Manhattan in New York City. It is by far the world's largest stock exchange by market capitalization of its listed companies at US$30.1 trillion as of February 2018.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Treasury_stock">Treasury stock</a></td>
      <td>A treasury stock or reacquired stock is stock which is bought back by the issuing company, reducing the amount of outstanding stock on the open market ("open market" including insiders' holdings). \nStock repurchases are used as a tax efficient method to put cash into shareholders' hands, rather than paying dividends, in jurisdictions that treat capital gains more favorably.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Convertible_bond">Convertible bond</a></td>
      <td>In finance, a convertible bond or  convertible note or convertible debt (or a convertible debenture if it has a maturity of greater than 10 years) is a type of bond that the holder can convert into a specified number of shares of common stock in the issuing company or cash of equal value.  It is a hybrid security with debt- and equity-like features.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>NANOPHASE TECHNOLOGIES CORPORATION      Item 1A Risk factors for <font color="blue">additional</font> discussion</td>
    </tr>
    <tr>
      <td>Forward-Looking Statements        Nanophase  wants  to <font color="blue">provide investors with</font> more <font color="blue">meaningful</font> and useful     information</td>
    </tr>
    <tr>
      <td>As a result, this <font color="blue">Annual Report </font>on Form 10-K (the “Form 10-K”)     contains   and  <font color="blue">incorporates</font>  by  reference  certain  “forward-looking     statements”, as defined in Section 21E of the <font color="blue">Securities <font color="blue">Exchange Act </font></font>of     1934,  as  amended</td>
    </tr>
    <tr>
      <td>These  statements  reflect  the Company’s current     <font color="blue">expectations</font>  of the future results of its <font color="blue">operations</font>, performance and     <font color="blue"><font color="blue">achievement</font>s</font></td>
    </tr>
    <tr>
      <td>Forward-looking statements are <font color="blue">covered under</font> the <font color="blue">safe harbor</font>     provisions of the <font color="blue">Private Securities Litigation Reform Act </font>of 1995</td>
    </tr>
    <tr>
      <td>The     Company has tried, wherever possible, to identify these <font color="blue">statements by using</font>     words such as “anticipates”, “believes”, “estimates”, “expects”, “plans”,     “intends” and similar <font color="blue">expressions</font></td>
    </tr>
    <tr>
      <td>These statements reflect <font color="blue">management</font>’s     current  beliefs  and  are  based  on information now available to it</td>
    </tr>
    <tr>
      <td>Accordingly, these statements are subject to certain risks, <font color="blue">uncertainties</font>     and <font color="blue">contingencies</font> that could cause the Company’s actual results, performance     or <font color="blue"><font color="blue">achievement</font>s</font> in 2006 and beyond to <font color="blue">differ <font color="blue">materially</font> from</font> those expressed     in, or implied by, such statements</td>
    </tr>
    <tr>
      <td>These risks, <font color="blue">uncertainties</font> and factors     include, <font color="blue">without limitation</font>: a <font color="blue">decision by</font> a customer to cancel a purchase     order or <font color="blue">supply <font color="blue">agreement</font></font> in light of the Company’s <font color="blue">dependence on</font> a limited     number  of key customers; uncertain demand for, and <font color="blue">acceptance</font> of, the     Company’s <font color="blue"><font color="blue">nanocrystalline</font> materials</font>; the Company’s <font color="blue"><font color="blue">manufacturing</font> capacity</font>     and <font color="blue">product mix flexibility</font> in light of <font color="blue">customer demand</font>; the Company’s     limited  marketing experience; changes in <font color="blue">development</font> and <font color="blue">distribution</font>     <font color="blue">relationships</font>; the impact of <font color="blue"><font color="blue">competitive</font> products</font> and <font color="blue">technologies</font>; the     Company’s <font color="blue">dependence on</font> patents and protection of <font color="blue">proprietary</font> information;     the resolution of <font color="blue">litigation</font> in which the Company <font color="blue">may become involved</font>; and     other <font color="blue">risks set forth under</font> the caption “Risk Factors” below</td>
    </tr>
    <tr>
      <td>Readers of     this <font color="blue">Annual Report </font>on Form 10-K should not place <font color="blue">undue reliance on</font> any     forward-looking statements</td>
    </tr>
    <tr>
      <td>Except as required <font color="blue">by federal securities laws</font>,     the  <font color="blue">Company  </font>undertakes  no  <font color="blue">obligation</font>  to  update  or  revise these     forward-looking statements to <font color="blue">reflect new events</font> or <font color="blue">uncertainties</font></td>
    </tr>
    <tr>
      <td>Investor Information        <font color="blue">The Company </font>is subject to the informational <font color="blue">requirement</font>s of the Securities     <font color="blue">Exchange Act </font>of 1934 (the Exchange Act) and, <font color="blue">accordingly</font>, files periodic     reports, <font color="blue">proxy statements</font> and other information with the Securities and     Exchange Commission (the SEC)</td>
    </tr>
    <tr>
      <td>Such reports, <font color="blue">proxy statements</font> and other     information may be obtained by visiting the <font color="blue">Public Reference Room of the SEC     </font>at 450 Fifth Street, NW, Washington, DC 20549 or by calling the SEC at     1-800-SEC-0330</td>
    </tr>
    <tr>
      <td>gov) that contains reports, proxy and information statements     and other information regarding issuers that <font color="blue">file electronically</font></td>
    </tr>
    <tr>
      <td><font color="blue">Financial </font>and other information may also be <font color="blue">accessed at</font> the Company’s web     site</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>makes available, free of     charge, copies of its annual report on Form 10-K, quarterly reports on <font color="blue">Form     </font>10-Q, current reports on Form 8-K and <font color="blue"><font color="blue">amendment</font>s</font> to those reports filed or     <font color="blue">furnished pursuant</font> to Section 13(a) or 15(d) of <font color="blue">the <font color="blue">Exchange Act </font></font>as soon as     <font color="blue">reasonably practicable</font> after <font color="blue">filing such</font> material <font color="blue">electronically with</font>, or     <font color="blue">otherwise furnishing</font> it to, the SEC, and intends to make all such reports     and <font color="blue"><font color="blue">amendment</font>s</font> to reports <font color="blue">available free</font> of charge on its web site</td>
    </tr>
    <tr>
      <td>Item 1A <font color="blue">Risk Factors </font>       The following risks, <font color="blue">uncertainties</font>, and other <font color="blue">factors could</font> have a material     adverse effect on our business, <font color="blue">financial condition</font>, operating results and     <font color="blue">growth prospects</font></td>
    </tr>
    <tr>
      <td>9     ______________________________________________________________________    [10]Table of <font color="blue">Contents       </font>We  have  a  limited  operating history and may not be able to address     <font color="blue"><font color="blue">difficult</font>ies</font>  <font color="blue">encountered</font>  <font color="blue">by <font color="blue">early stage</font> companies</font> in new and rapidly     <font color="blue">evolving markets</font></td>
    </tr>
    <tr>
      <td>We were formed in November 1989     and began our commercial <font color="blue"><font color="blue">nanocrystalline</font> materials</font> <font color="blue">operations</font> in <font color="blue">January     </font>1997</td>
    </tr>
    <tr>
      <td>We have not yet generated a <font color="blue"><font color="blue">significant</font> amount</font> of <font color="blue">revenue from</font> our     <font color="blue"><font color="blue">nanocrystalline</font> materials</font> <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Because of our limited operating     history and the <font color="blue">early stage</font> of <font color="blue">development</font> of our <font color="blue">rapidly evolving market</font>,     we have limited <font color="blue">insight into trends</font> that may emerge and <font color="blue"><font color="blue">adversely</font> affect</font> our     business and cannot be certain that our business <font color="blue">strategy will</font> be successful     or that it <font color="blue">will successfully address</font> these risks</td>
    </tr>
    <tr>
      <td>In addition, our efforts     to address any of these <font color="blue">risks may distract personnel</font> or <font color="blue">divert resources</font>     from other more <font color="blue">important initiatives</font>, such as attracting and retaining     customers and responding to <font color="blue"><font color="blue">competitive</font> market conditions</font></td>
    </tr>
    <tr>
      <td>We have a history of losses that <font color="blue">may continue</font> in the future</td>
    </tr>
    <tr>
      <td>We have incurred net losses in <font color="blue">each year since</font> our <font color="blue">inception with net losses</font>     of dlra5dtta83 million in 2003, dlra6dtta45 million in 2004 and dlra5dtta38 million in 2005</td>
    </tr>
    <tr>
      <td><font color="blue">As of <font color="blue">December </font></font>31, 2005, we had an <font color="blue">accumulated deficit</font> of <font color="blue">approximately</font>     dlra57dtta57 million and presently expect to continue to <font color="blue">incur losses on</font> an annual     basis  through  at least the end of 2006</td>
    </tr>
    <tr>
      <td>We believe that our business     depends,  among other things, on our ability to <font color="blue"><font color="blue">significant</font>ly increase</font>     revenue</td>
    </tr>
    <tr>
      <td>If revenue fails to grow at anticipated rates or if operating     <font color="blue">expenses increase without</font> a <font color="blue">commensurate increase</font> in revenue, or if we fail     to adjust operating expense levels <font color="blue">accordingly</font>, then the <font color="blue">imbalance between</font>     revenue and operating <font color="blue">expenses will negatively impact</font> our <font color="blue">cash balances</font> and     our ability to achieve <font color="blue">profitability</font> in <font color="blue">future periods</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> a small number of customers for a <font color="blue">high percentage</font> of our sales,     and the loss of <font color="blue">orders from</font> a <font color="blue"><font color="blue">significant</font> customer could</font> cause a decline in     revenue and/or increases in the level of <font color="blue">losses incurred</font></td>
    </tr>
    <tr>
      <td>We expect a <font color="blue">significant</font> portion of our     <font color="blue">future sales</font> to <font color="blue">remain concentrated within</font> a limited number of strategic     customers</td>
    </tr>
    <tr>
      <td>We may not be able to retain our strategic customers, such     <font color="blue"><font color="blue">customers may</font> cancel</font> or <font color="blue">reschedule orders</font>, or in the event of canceled     orders, such orders may not be <font color="blue">replaced by</font> other sales or by sales that are     on as favorable terms</td>
    </tr>
    <tr>
      <td>In addition, sales to any <font color="blue">particular customer may</font>     fluctuate <font color="blue">significant</font>ly from quarter to quarter, which could affect our     ability to achieve anticipated <font color="blue">revenues on</font> a <font color="blue">quarterly basis</font></td>
    </tr>
    <tr>
      <td>(formerly  known  as  “Rodel”)  and  CI  Kasei, a division of Itochu     Corporation, accounted for <font color="blue">approximately</font> 83prca of <font color="blue">total revenue</font> for the year     ended <font color="blue">December </font>31, 2005, and <font color="blue">revenue from</font> the <font color="blue">same three customers accounted</font>     for  <font color="blue">approximately</font>  89prca  of <font color="blue">total revenue</font> in 2004</td>
    </tr>
    <tr>
      <td>For the years ended     <font color="blue">December </font>31, 2005 and 2004, BASF accounted for 66prca and 70prca of our total     revenue,  <font color="blue">respectively</font></td>
    </tr>
    <tr>
      <td>If  we were to lose, or receive <font color="blue">significant</font>ly     decreased <font color="blue">orders from</font>, any of these three customers, then our results of     <font color="blue"><font color="blue">operations</font> would</font> be <font color="blue"><font color="blue">materially</font> harmed</font></td>
    </tr>
    <tr>
      <td>While our <font color="blue"><font color="blue"><font color="blue">agreement</font>s</font> with</font> our two     <font color="blue"><font color="blue">largest customer</font>s</font> are long-term <font color="blue"><font color="blue">agreement</font>s</font>, they may be <font color="blue">terminated by</font> the     <font color="blue">customer with reasonable</font> notice and do not provide any <font color="blue">guarantees</font> that these     customers  will  continue  to buy our products</td>
    </tr>
    <tr>
      <td>In addition, while our     <font color="blue"><font color="blue">agreement</font>s</font>  with  our  two  largest  customers  contain  minimum order     <font color="blue">requirement</font>s, the <font color="blue">only repercussion under</font> the <font color="blue"><font color="blue">agreement</font>s</font> for missing the     minimum order <font color="blue">requirement</font> is that we would be <font color="blue">freed from</font> the <font color="blue">exclusivity</font>     <font color="blue">obligation</font>s under these contracts</td>
    </tr>
    <tr>
      <td>We  have  been  <font color="blue">consistently expanding both</font> our marketing and business     <font color="blue">development</font> efforts and our <font color="blue">production efficiency</font> in order to address the     issues of our <font color="blue">dependence upon</font> a limited amount of customers, enhancement of     gross profit and operating <font color="blue">cash flows</font>, and the <font color="blue">achievement</font> of <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>We currently have customers that may grow to the point where they generate     <font color="blue">significant</font> revenues and                                           10     ______________________________________________________________________    [11]Table of <font color="blue">Contents       </font><font color="blue">margins as</font> <font color="blue">relationships</font> expand</td>
    </tr>
    <tr>
      <td>Given the special nature of our products,     and  the fact that markets for them are not yet fully developed, it is     <font color="blue">difficult</font>  to  <font color="blue">accurately</font> predict when <font color="blue">additional</font> large customers will     <font color="blue">materialize</font></td>
    </tr>
    <tr>
      <td>Going forward, the Company’s margins, as a percentage of     revenue,  will  be  dependent upon revenue mix, <font color="blue">revenue volume</font> and the     Company’s ability to continue to cut costs</td>
    </tr>
    <tr>
      <td>The extent of the growth in     <font color="blue">revenue volume</font> and the related gross profit that this <font color="blue">revenue generates</font>,     will be the <font color="blue">main drivers</font> in <font color="blue">generating</font> positive operating <font color="blue">cash flows</font> and,     ultimately, net income</td>
    </tr>
    <tr>
      <td>Any downturn in the <font color="blue">markets served by us would harm</font> our business</td>
    </tr>
    <tr>
      <td>A  majority  of  our  products  are <font color="blue">incorporated into products such as</font>     sunscreens, polishing slurries, personal care, and to a <font color="blue">lesser extent</font>,     medical diagnostics, abrasion-resistant coatings for flooring, and other     products</td>
    </tr>
    <tr>
      <td>These  markets have from time to time experienced cyclical,     depressed business conditions, often in <font color="blue">connection with</font>, or in <font color="blue">anticipation</font>     of, a decline in <font color="blue">general economic conditions</font></td>
    </tr>
    <tr>
      <td>These industry downturns have     resulted in <font color="blue">reduced product demand</font> and <font color="blue">declining average selling prices</font></td>
    </tr>
    <tr>
      <td>Our     business would be <font color="blue">harmed by</font> any <font color="blue">future downturns</font> in the markets that we     serve</td>
    </tr>
    <tr>
      <td>Our <font color="blue">products often</font> have <font color="blue">long adoption cycle</font>s, which could make it <font color="blue">difficult</font>     to achieve market <font color="blue">acceptance</font> and makes it <font color="blue">difficult</font> to <font color="blue">forecast revenues</font></td>
    </tr>
    <tr>
      <td>Due to their often novel <font color="blue">characteristics</font> and the <font color="blue">unfamiliarity with them</font>     that exists in the marketplace, our <font color="blue"><font color="blue">nanocrystalline</font> materials</font> often require     longer  adoption  cycles  than  existing  materials  <font color="blue">technologies</font></td>
    </tr>
    <tr>
      <td>Our     <font color="blue">nanomaterials</font> have to receive <font color="blue">appropriate attention within</font> any potential     customer’s organization, then they must be tested to prove a performance     advantage over <font color="blue">existing materials</font>, typically on a systems-cost basis</td>
    </tr>
    <tr>
      <td><font color="blue">Once     </font>we have proven initial commercial viability, pilot scale production runs     must  be  completed by the customer, followed by further testing</td>
    </tr>
    <tr>
      <td><font color="blue">Once     </font>production-level commercial viability is established, then our <font color="blue">nanomaterials</font>     can  be introduced, often to a <font color="blue">downstream marketplace</font> that needs to be     <font color="blue">familiarized with them</font></td>
    </tr>
    <tr>
      <td>If we are unable to convince our <font color="blue">potential customers</font>     of the <font color="blue">performance advantages</font> and <font color="blue">economic value</font> of our <font color="blue">nanocrystalline</font>     <font color="blue">materials over existing</font> and <font color="blue">competing materials</font> and <font color="blue">technologies</font>, we will be     unable to generate <font color="blue">significant</font> sales</td>
    </tr>
    <tr>
      <td>Our <font color="blue">long adoption cycle</font> makes it     <font color="blue">difficult</font> to predict when <font color="blue">sales will</font> occur</td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> collaborative <font color="blue">development</font> <font color="blue">relationships</font> with our customers and     do not have a substantial <font color="blue">direct sales force</font> or an established <font color="blue">distribution</font>     <font color="blue">network apart from</font> the <font color="blue">distribution</font> networks of our <font color="blue">strategic partners</font></td>
    </tr>
    <tr>
      <td>If     we are unable to initiate or sustain such collaborative <font color="blue">relationships</font> or if     the terms of these <font color="blue">relationships</font> limit the <font color="blue">distribution</font> of our products or     if our <font color="blue">strategic partners</font> are unable to distribute our <font color="blue">products <font color="blue">efficient</font>ly</font>,     then we may be unable to <font color="blue">independently</font> develop, <font color="blue">manufacture</font> or market our     current and future <font color="blue"><font color="blue">nanocrystalline</font> materials</font> or <font color="blue">applications</font></td>
    </tr>
    <tr>
      <td>We have established, and <font color="blue">will continue</font> to pursue, strategic <font color="blue">relationships</font>     with many of our customers and do not have a substantial <font color="blue">direct sales force</font>     or an established <font color="blue">distribution</font> network (other than <font color="blue">distribution</font> arrangements     for <font color="blue">research samples</font>)</td>
    </tr>
    <tr>
      <td>Through these <font color="blue">relationships</font>, we seek to develop new     <font color="blue">applications</font> for our <font color="blue"><font color="blue">nanocrystalline</font> materials</font> and share <font color="blue">development</font> and     <font color="blue">manufacturing</font>  resources</td>
    </tr>
    <tr>
      <td>We also seek to coordinate the <font color="blue">development</font>,     <font color="blue">manufacture</font> and marketing of our <font color="blue">nanocrystalline</font> products</td>
    </tr>
    <tr>
      <td>Future success     will depend, in part, on our continued <font color="blue">relationships</font> with these customers     and our ability to <font color="blue">enter into</font> similar strategic <font color="blue">relationships</font> with other     customers</td>
    </tr>
    <tr>
      <td>Our <font color="blue">customers may</font> not continue in these collaborative <font color="blue">development</font>     <font color="blue">relationships</font>, may not <font color="blue">devote sufficient resources</font> to the <font color="blue">development</font> or     sale of our materials or may <font color="blue">enter into</font> strategic <font color="blue">development</font> <font color="blue">relationships</font>     with our <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">customers may</font> also require a share of control of     these <font color="blue">collaborative programs</font></td>
    </tr>
    <tr>
      <td>Some of our <font color="blue"><font color="blue"><font color="blue">agreement</font>s</font> with</font> these customers     limit our ability to license our <font color="blue">technology</font> to others and/or limit our     ability to engage in certain product <font color="blue">development</font> or marketing <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">relationships</font> generally can be <font color="blue">terminated unilaterally by customers</font></td>
    </tr>
    <tr>
      <td><font color="blue">Additionally </font>and except for our research quantities <font color="blue">distribution</font> <font color="blue">agreement</font>     with Alfa Aesar, these                                           11     ______________________________________________________________________    [12]Table of <font color="blue">Contents       </font>customers generally require exclusive <font color="blue">distribution</font> arrangements within the     field of <font color="blue">application covered by</font> our <font color="blue">agreement</font> with these customers, and the     very nature of these strategic <font color="blue">relationships</font> limits the <font color="blue">distribution</font> of our     products  to  the  <font color="blue">distribution</font>  networks  available  to our strategic     <font color="blue">relationship partners</font></td>
    </tr>
    <tr>
      <td>In addition, the <font color="blue">development</font> <font color="blue"><font color="blue"><font color="blue">agreement</font>s</font> with</font> some of     our <font color="blue">larger customers contain provisions</font> that require us to license our     <font color="blue"><font color="blue">intellectual</font> property</font> to these <font color="blue">customers on</font> disadvantaged terms and/or     <font color="blue">transfer equipment</font> to these customers in the event that we <font color="blue"><font color="blue">materially</font> breach</font>     these  <font color="blue"><font color="blue">agreement</font>s</font>  or fail to <font color="blue">satisfy certain financial covenants</font></td>
    </tr>
    <tr>
      <td>For     example, see “Risk Factors—We may need to raise <font color="blue">additional</font> capital in the     future</td>
    </tr>
    <tr>
      <td>”       If we are unable to initiate or sustain such collaborative <font color="blue">relationships</font> or     if  the  terms  of  these <font color="blue">relationships</font> <font color="blue">materially</font> limit our access to     <font color="blue">distribution</font>  channels  for  our  products,  then  we may be unable to     <font color="blue">independently</font>  develop,  <font color="blue">manufacture</font>  or market our current and future     <font color="blue"><font color="blue">nanocrystalline</font> materials</font> or <font color="blue">applications</font></td>
    </tr>
    <tr>
      <td>If commodity <font color="blue">metal prices increased at such</font> a rate that we are unable to     recover  lost  margins  on  a <font color="blue">timely basis</font> or that our <font color="blue">products became</font>     <font color="blue">un<font color="blue">competitive</font></font> in their <font color="blue">current marketplaces</font>, our financial and liquidity     position and results of <font color="blue"><font color="blue">operations</font> would</font> be <font color="blue"><font color="blue">substantially</font> harmed</font></td>
    </tr>
    <tr>
      <td>Many of our <font color="blue">significant</font> raw materials come from commodity metal markets that     may be subject to rapid price increases</td>
    </tr>
    <tr>
      <td>While we <font color="blue">generally pass</font> commodity     <font color="blue">price increases on</font> to our customers, it is possible that, given our limited     <font color="blue">customer base</font> and the limited control we have over it, commodity metal     prices  <font color="blue">could increase at such</font> a rate that <font color="blue">could hinder</font> our ability to     recover  <font color="blue">lost margins from</font> our <font color="blue">customers on</font> a <font color="blue">timely basis</font></td>
    </tr>
    <tr>
      <td>It is also     possible that <font color="blue">such drastic cost increases could</font> render some of our materials     <font color="blue">un<font color="blue">competitive</font></font> in their <font color="blue">current marketplaces</font> when considered relative to     other  <font color="blue">materials on</font> a <font color="blue">cost benefit basis</font></td>
    </tr>
    <tr>
      <td>If either of these potential     results  occurred, our financial and <font color="blue">liquidity position</font> and results of     <font color="blue"><font color="blue">operations</font> would</font> be <font color="blue"><font color="blue">substantially</font> harmed</font></td>
    </tr>
    <tr>
      <td>If a <font color="blue">catastrophe</font> strikes either of our <font color="blue">manufacturing</font> <font color="blue">facilities</font> or if we     were to lose our lease for either <font color="blue">facility</font> due to non-renewal or other     <font color="blue">unforeseen events</font>, we may be unable to <font color="blue">manufacture</font> our materials to meet     customers’ demands</td>
    </tr>
    <tr>
      <td>Our <font color="blue">manufacturing</font> <font color="blue">facilities</font> are located in Romeoville and Burr Ridge,     Illinois</td>
    </tr>
    <tr>
      <td>These  <font color="blue">facilities</font> and some of our <font color="blue">manufacturing</font> and testing     <font color="blue">equipment would</font> be <font color="blue">difficult</font> to replace in a <font color="blue">timely manner</font></td>
    </tr>
    <tr>
      <td>Therefore, any     material <font color="blue">disruption</font> at one of our <font color="blue">facilities</font> due to a natural or man-made     disaster or a loss of lease due to non-renewal or other <font color="blue">unforeseen events</font>     could have a material adverse effect on our ability to <font color="blue">manufacture</font> products     to meet customers’ demands</td>
    </tr>
    <tr>
      <td>While we maintain <font color="blue">customary property insurance</font>,     this <font color="blue">insurance may</font> not <font color="blue">adequately <font color="blue">compensate us</font></font> for all losses that we may     incur and would not <font color="blue">compensate us</font> for any <font color="blue">interruption</font> in our business</td>
    </tr>
    <tr>
      <td>If we are unable to expand our <font color="blue">production capabilities</font> to <font color="blue">meet unexpected</font>     demand, we may be unable to manage our growth and our business <font color="blue">would suffer</font></td>
    </tr>
    <tr>
      <td>Our  success  will  depend,  in  part,  on  our ability to <font color="blue">manufacture</font>     <font color="blue"><font color="blue">nanocrystalline</font> materials</font> in <font color="blue">significant</font> quantities, with consistent quality     and in an <font color="blue">efficient</font> and <font color="blue">timely manner</font></td>
    </tr>
    <tr>
      <td>We expect to continue to expand our     current <font color="blue">facilities</font> or obtain <font color="blue">additional</font> <font color="blue">facilities</font> in the future in order to     respond to <font color="blue">unexpected demand</font> for <font color="blue">existing materials</font> or for <font color="blue">new materials</font>     that we do not currently make in quantity</td>
    </tr>
    <tr>
      <td>Such <font color="blue">unplanned demand</font>, if it     resulted in rapid expansion, could create a situation where <font color="blue">growth could</font>     become <font color="blue">difficult</font> to manage, which could cause us to <font color="blue">lose potential revenue</font></td>
    </tr>
    <tr>
      <td><font color="blue">Protection </font>of our <font color="blue"><font color="blue">intellectual</font> property</font> is limited and uncertain</td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">intellectual</font> property</font> is important to our business</td>
    </tr>
    <tr>
      <td>We seek to protect     our <font color="blue"><font color="blue">intellectual</font> property</font> through patent, trademark, trade secret protection     and <font color="blue">confidentiality</font> or license <font color="blue"><font color="blue"><font color="blue">agreement</font>s</font> with</font> our                                           12     ______________________________________________________________________    [13]Table of <font color="blue">Contents       </font>employees, customers, suppliers and others</td>
    </tr>
    <tr>
      <td>Our means of protecting our     <font color="blue"><font color="blue">intellectual</font> property</font> rights in the <font color="blue">United States </font>or abroad may not be     adequate and others, including our <font color="blue">competitors</font>, may use our <font color="blue">proprietary</font>     <font color="blue">technology</font> without our consent</td>
    </tr>
    <tr>
      <td>We may not receive the <font color="blue"><font color="blue">necessary</font> patent</font>     protection for any <font color="blue">applications</font> pending with the US Patent and Trademark     Office (“USPTO”) and any of the patents that we currently own or <font color="blue">license may</font>     not be sufficient to keep <font color="blue">competitors</font> from using our materials or processes</td>
    </tr>
    <tr>
      <td>In addition, patents that we currently own or <font color="blue">license may</font> not be held valid     if <font color="blue">subsequently challenged by others</font> and <font color="blue">others may</font> claim rights in the     patents  and  other  <font color="blue">proprietary</font>  <font color="blue">technology</font>  that  we own or license</td>
    </tr>
    <tr>
      <td>Additionally, <font color="blue">others may</font> have already developed or <font color="blue">may subsequently</font> develop     similar products or <font color="blue">technologies</font> without violating any of our <font color="blue">proprietary</font>     rights</td>
    </tr>
    <tr>
      <td>If  we fail to obtain <font color="blue">patent protection</font> or preserve our trade     secrets, we may be unable to <font color="blue">effectively compete against others offering</font>     similar products and services</td>
    </tr>
    <tr>
      <td>In addition, if we fail to operate without     infringing  the  <font color="blue">proprietary</font>  rights  of others or lose any license to     <font color="blue">technology</font> that we currently have or will acquire in the future, we may be     unable to continue making the products that we currently make</td>
    </tr>
    <tr>
      <td>Moreover, at times, attempts may be made to challenge the <font color="blue">prior issuance</font> of     our patents</td>
    </tr>
    <tr>
      <td>For example, the USPTO has granted a third-party request for     re-examination  with  respect  to  one  patent  relating to one of our     <font color="blue">nanoparticle</font>   <font color="blue">manufacturing</font>  processes</td>
    </tr>
    <tr>
      <td>On  <font color="blue">September </font>7,  2005,  our     <font color="blue">representatives conducted</font> an interview with the Examiner assigned to the     re-examination  at  the  USPTO, resulting in the Examiner preparing an     <font color="blue">interview summary indicating</font> that the Examiner agreed that all the issued     claims were patentable</td>
    </tr>
    <tr>
      <td>However, prior to the USPTO issuing a formal notice     <font color="blue">confirming patentability</font>, the <font color="blue">same third party filed</font> a <font color="blue">second request</font> for     re-examination of the patent (which <font color="blue">second request</font>, the USPTO has since     denied)</td>
    </tr>
    <tr>
      <td>Nonetheless, a second interview was conducted, resulting in an     <font color="blue">amendment</font> to all patent claims</td>
    </tr>
    <tr>
      <td>While we <font color="blue">will continue</font> to <font color="blue">vigorously defend</font>     our <font color="blue">patent position</font>, we may not be successful in maintaining the scope of     the claims of this patent during re-examination</td>
    </tr>
    <tr>
      <td>If our patent claims are     narrowed  <font color="blue"><font color="blue">substantially</font> by</font> the USPTO, the patent coverage afforded our     <font color="blue">nanoparticle</font> <font color="blue">manufacturing</font> process could be impaired</td>
    </tr>
    <tr>
      <td>While we would not     expect  <font color="blue">such impairment</font> to affect the value of our <font color="blue">manufacturing</font> trade     secrets that have not been disclosed in the patent, it <font color="blue">could impede</font> the     extent of our <font color="blue">legal protection</font> of the invention that is subject to this     patent and <font color="blue">potentially harm</font> our business and operating results</td>
    </tr>
    <tr>
      <td>Furthermore,  <font color="blue">litigation</font>  may be <font color="blue">necessary</font> to enforce our <font color="blue">intellectual</font>     <font color="blue">property rights</font>, to protect our <font color="blue">trade secrets</font>, to determine the validity and     scope of the <font color="blue">proprietary</font> rights of others, or to <font color="blue">defend against</font> claims of     <font color="blue">infringement</font> or <font color="blue">invalidity</font></td>
    </tr>
    <tr>
      <td>Such <font color="blue">litigation</font> could result in substantial     costs and diversion of resources and <font color="blue">could harm</font> our business, operating     results and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>In addition, if others assert that our     <font color="blue">technology</font> infringes their <font color="blue"><font color="blue">intellectual</font> property</font> rights, resolving the     <font color="blue">dispute could divert</font> our <font color="blue"><font color="blue">management</font> team</font> and <font color="blue">financial resources</font></td>
    </tr>
    <tr>
      <td>In the future, we may license certain of our <font color="blue"><font color="blue">intellectual</font> property</font>, such as     <font color="blue">trademarks</font> or copyrighted material, to third parties</td>
    </tr>
    <tr>
      <td>While we <font color="blue">would attempt</font>     to ensure that any licensees maintain the quality and value of our brand,     these <font color="blue">licenses might diminish</font> this quality and value</td>
    </tr>
    <tr>
      <td>We may be subject to claims that one or more of the business <font color="blue">methods used by</font>     us  <font color="blue">infringe upon patents</font> held by others</td>
    </tr>
    <tr>
      <td>The defense of any claims of     <font color="blue">infringement</font> made <font color="blue">against us</font> by third parties could involve <font color="blue">significant</font>     <font color="blue">legal costs</font> and require our <font color="blue">management</font> to divert time and other resources     from  our  business  <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Either  of  these <font color="blue">consequences</font> of an     <font color="blue">infringement</font> claim could have a material adverse effect on our operating     results</td>
    </tr>
    <tr>
      <td>If we are <font color="blue">unsuccessful</font> in defending any claims of <font color="blue">infringement</font>, we     may be forced to obtain licenses or <font color="blue">pay royalties</font> to continue to use our     <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>We  may  not  be able to obtain any <font color="blue">necessary</font> licenses on     <font color="blue">commercially reasonable terms</font> or at all</td>
    </tr>
    <tr>
      <td>If we fail to obtain <font color="blue">necessary</font>     licenses or other rights, or if these licenses are costly, our operating     results <font color="blue">may suffer either from reductions</font> in <font color="blue">revenue through</font> our <font color="blue">inability</font>     to  serve  clients  or  <font color="blue">from increases</font> in costs to license third-party     <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>13     ______________________________________________________________________    [14]Table of <font color="blue">Contents       </font>Our industry is experiencing rapid changes in <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>Rapid changes have occurred, and are likely to continue to occur, in the     <font color="blue">development</font> of <font color="blue">advanced materials</font> and processes</td>
    </tr>
    <tr>
      <td>Our <font color="blue">success will depend</font>, in     large  part,  upon  our  ability  to keep pace with <font color="blue">advanced materials</font>     <font color="blue">technologies</font>,  <font color="blue">industry standards</font> and <font color="blue">market trends</font> and to develop and     <font color="blue">introduce new</font> and <font color="blue">improved products on</font> a <font color="blue">timely basis</font></td>
    </tr>
    <tr>
      <td>We expect to commit     substantial resources to develop our <font color="blue">technologies</font> and product <font color="blue">applications</font>     and, in the future, to expand our commercial <font color="blue"><font color="blue">manufacturing</font> capacity</font> as     volume  grows</td>
    </tr>
    <tr>
      <td>Our <font color="blue">development</font> efforts may be rendered <font color="blue">obsolete by</font> the     <font color="blue">research efforts</font> and <font color="blue">technological advances</font> of others and other advanced     <font color="blue">materials may prove</font> more <font color="blue">advantageous than</font> those we produce</td>
    </tr>
    <tr>
      <td>Our  market  is  highly  <font color="blue">competitive</font>,  and if we are unable to compete     effectively, then our business will not grow</td>
    </tr>
    <tr>
      <td>The <font color="blue">advanced materials</font> industry is new, rapidly evolving and intensely     <font color="blue">competitive</font>, and we expect <font color="blue">competition</font> to intensify in the future</td>
    </tr>
    <tr>
      <td>The     market for materials having the <font color="blue">characteristics</font> and <font color="blue">potential uses</font> of our     <font color="blue">nanocrystalline</font>  materials  is  the  subject of <font color="blue">intensive research</font> and     <font color="blue">development</font> efforts by both governmental entities and <font color="blue">private enterprises</font>     around the world</td>
    </tr>
    <tr>
      <td>We believe that the level of <font color="blue">competition</font> will increase     <font color="blue">further as</font> more product <font color="blue">applications</font> with <font color="blue">significant</font> commercial potential     are  developed</td>
    </tr>
    <tr>
      <td>The  <font color="blue">nanocrystalline</font> product <font color="blue">applications</font> that we are     developing  will  compete  directly  with  <font color="blue">products incorporating both</font>     <font color="blue">conventional</font> and <font color="blue">advanced materials</font> and <font color="blue">technologies</font></td>
    </tr>
    <tr>
      <td>While we are not     <font color="blue">currently aware</font> of the existence of commercially available <font color="blue">competitive</font>     <font color="blue">products with</font> the <font color="blue">same attributes as</font> those we offer, other <font color="blue">companies may</font>     develop and <font color="blue">introduce new</font> or <font color="blue"><font color="blue">competitive</font> products</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">competitors</font> may     succeed in developing or marketing materials, <font color="blue">technologies</font> and better or     <font color="blue">less expensive products than</font> the ones we offer</td>
    </tr>
    <tr>
      <td>In addition, many of our     potential <font color="blue">competitors</font> have <font color="blue"><font color="blue">substantially</font> greater financial</font> and technical     resources, and greater <font color="blue">manufacturing</font> and <font color="blue">marketing capabilities than</font> we do</td>
    </tr>
    <tr>
      <td>If we fail to improve our current and potential <font color="blue">nanocrystalline</font> product     <font color="blue">applications</font> at an acceptable price, or <font color="blue">otherwise compete with producers</font> of     <font color="blue">conventional</font>  materials,  we <font color="blue">will lose market</font> share and revenue to our     <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>We may need to raise <font color="blue">additional</font> capital in the future</td>
    </tr>
    <tr>
      <td>If we are unable to     obtain <font color="blue">adequate funds</font>, we may be required to delay, scale-back or eliminate     some of our <font color="blue">manufacturing</font> and marketing <font color="blue">operations</font> or we may need to obtain     <font color="blue">funds through arrangements on less</font> favorable terms or we may be required to     <font color="blue">transfer equipment</font> to our <font color="blue">largest customer</font></td>
    </tr>
    <tr>
      <td>We expect to expend <font color="blue">significant</font> resources on research, <font color="blue">development</font> and     <font color="blue">product testing</font>, and in <font color="blue">expanding current capacity</font> or <font color="blue">capability</font> for new     business</td>
    </tr>
    <tr>
      <td>In addition, we may incur <font color="blue">significant</font> costs in preparing, filing,     prosecuting, maintaining and enforcing our patents and other <font color="blue">proprietary</font>     rights</td>
    </tr>
    <tr>
      <td>If  <font color="blue">necessary</font>,  we <font color="blue">may seek funding through public</font> or private     financing  and  through  <font color="blue">contracts with government</font> or other companies</td>
    </tr>
    <tr>
      <td><font color="blue">Additional </font><font color="blue">financing may</font> not be <font color="blue">available on</font> acceptable terms or at all</td>
    </tr>
    <tr>
      <td>If     we  are  unable to obtain <font color="blue">adequate funds</font>, we may be required to delay,     scale-back or eliminate some of our <font color="blue">manufacturing</font> and marketing <font color="blue">operations</font>     or we may need to obtain <font color="blue">funds through arrangements on less</font> favorable terms</td>
    </tr>
    <tr>
      <td>If we obtain <font color="blue">funding on unfavorable terms</font>, we may be required to <font color="blue">relinquish</font>     rights to some of our <font color="blue"><font color="blue">intellectual</font> property</font></td>
    </tr>
    <tr>
      <td>To raise <font color="blue">additional</font> funds in the future, we <font color="blue">would likely sell</font> our equity or     <font color="blue">debt securities</font> or <font color="blue">enter into</font> loan <font color="blue"><font color="blue">agreement</font>s</font></td>
    </tr>
    <tr>
      <td>To the extent that we issue     <font color="blue">debt securities</font> or <font color="blue">enter into</font> loan <font color="blue"><font color="blue">agreement</font>s</font>, we may become subject to     financial, operational and other covenants that we must observe</td>
    </tr>
    <tr>
      <td>In the     event that we were to breach any of these covenants, then the <font color="blue">amounts due</font>     <font color="blue">under such loans</font> or <font color="blue">debt securities</font> could become immediately payable by us,     which could <font color="blue">significant</font>ly harm us</td>
    </tr>
    <tr>
      <td>To the extent that we sell <font color="blue">additional</font>     shares of our equity securities, our <font color="blue">stockholders</font> may face economic dilution     and dilution of their percentage of ownership</td>
    </tr>
    <tr>
      <td>14     ______________________________________________________________________    [15]Table of <font color="blue">Contents       </font>We currently have a <font color="blue">supply <font color="blue">agreement</font></font> with BASF that <font color="blue">contains provisions</font>     <font color="blue">which could potentially</font> result in a <font color="blue">mandatory license</font> of <font color="blue">technology</font> and sale     of  production equipment to BASF <font color="blue">providing capacity sufficient</font> to meet     BASF’s production needs</td>
    </tr>
    <tr>
      <td>The license and related sale would be “triggered”     only in the event that we <font color="blue">breach certain</font> of our <font color="blue">obligation</font>s under the supply     <font color="blue">agreement</font> or one of the following occurs:           •   our earnings for a <font color="blue">twelve month period</font> ending with our <font color="blue">most recently</font>     <font color="blue">published quarterly financial statements</font> are <font color="blue">less than zero</font> and our cash,     <font color="blue">cash equivalents</font> and <font color="blue">investments</font> are less than dlra2cmam000cmam000, or           •   the <font color="blue">acceleration</font> of any <font color="blue">debt maturity</font> having a <font color="blue">principal amount</font> of     more than dlra10cmam000cmam000, or we <font color="blue">become insolvent as defined</font> in the supply     <font color="blue">agreement</font></td>
    </tr>
    <tr>
      <td>In the event of a <font color="blue">triggering event</font> where we are required to sell to BASF     production equipment <font color="blue">providing capacity sufficient</font> to meet BASF’s production     needs, the <font color="blue">equipment would</font> be sold at 115prca of the equipment’s net book     value</td>
    </tr>
    <tr>
      <td>We  believe  that  we have sufficient <font color="blue">cash balances</font> to avoid the first     <font color="blue">triggering event</font> through 2006</td>
    </tr>
    <tr>
      <td>If a <font color="blue">triggering event</font> were to occur and BASF     elected to <font color="blue">proceed with</font> the license and related sale mentioned above, we     would lose both <font color="blue">significant</font> revenue and the ability to generate <font color="blue">significant</font>     revenue to replace that which was lost in the near term</td>
    </tr>
    <tr>
      <td><font color="blue">Replacement </font>of     <font color="blue">necessary</font> equipment that would be purchased and removed by BASF pursuant to     this  <font color="blue">triggering event</font> could take six months to a year</td>
    </tr>
    <tr>
      <td>Any <font color="blue">additional</font>     <font color="blue">capital outlays</font> required to <font color="blue">rebuild capacity would probably</font> be <font color="blue">greater than</font>     the <font color="blue">proceeds from</font> the purchase of the <font color="blue">assets pursuant</font> to our <font color="blue">agreement</font> with     BASF This <font color="blue">shortfall might put us</font> in a position where it would be <font color="blue">difficult</font>     to secure <font color="blue">additional</font> funding given what would then be an <font color="blue">already tenuous</font>     <font color="blue">cash position</font></td>
    </tr>
    <tr>
      <td>Such an event would also result in the loss of many of our     key staff and <font color="blue">line employees due</font> to <font color="blue">economic realities</font></td>
    </tr>
    <tr>
      <td>We believe that our     employees are a critical component of our success and would be <font color="blue">difficult</font> to     <font color="blue">quickly replace</font> and train</td>
    </tr>
    <tr>
      <td>We <font color="blue">might elect</font> to <font color="blue">effectively reduce</font>     our size and staffing to a point where we <font color="blue">could remain</font> a going concern in     the near term</td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> <font color="blue">key personnel</font>, and their unplanned departure <font color="blue">could harm</font> our     business</td>
    </tr>
    <tr>
      <td>Our <font color="blue">success will depend</font>, in large part, upon our ability to attract and     retain <font color="blue">highly qualified research</font> and <font color="blue">development</font>, <font color="blue">management</font>, <font color="blue">manufacturing</font>,     marketing and <font color="blue">sales personnel on</font> favorable terms</td>
    </tr>
    <tr>
      <td>Due to the specialized     nature  of  our  business, we may have <font color="blue">difficult</font>y locating, hiring and     retaining <font color="blue">qualified personnel on</font> favorable terms</td>
    </tr>
    <tr>
      <td>If we were to lose the     services of any of our <font color="blue">key <font color="blue">executive officers</font></font> or other <font color="blue">key personnel</font>, or if     we are unable to attract and retain other skilled and experienced personnel     on  acceptable terms in the future, or if we are unable to implement a     succession plan to prepare <font color="blue">qualified individuals</font> to assume <font color="blue">key roles upon</font>     any loss of our <font color="blue">key personnel</font>, then our business, results of <font color="blue">operations</font> and     <font color="blue">financial condition</font> would be <font color="blue"><font color="blue">materially</font> harmed</font></td>
    </tr>
    <tr>
      <td>In addition, we do not     currently  have  “key-man” life insurance policies covering all of our     <font color="blue">executive officers</font> or key employees, nor do we presently have any plans to     <font color="blue">purchase such policies</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">face potential <font color="blue">product <font color="blue">liability</font></font> risks which could</font> result in <font color="blue">significant</font>     costs that exceed our <font color="blue">insurance coverage</font>, damage our reputation and harm our     business</td>
    </tr>
    <tr>
      <td>We may be subject to <font color="blue">product <font color="blue">liability</font></font> claims in the event that any of our     <font color="blue">nanocrystalline</font> product <font color="blue">applications</font> are alleged to be defective or cause     harmful  effects  to  humans  or  physical  <font color="blue">environments</font></td>
    </tr>
    <tr>
      <td>Because our     <font color="blue"><font color="blue">nanocrystalline</font> materials</font> are used in other companies’ products, to the     extent our <font color="blue">customers become</font> subject to suits relating to their products,     such as cosmetic, skin-care and personal-care products,                                           15     ______________________________________________________________________    [16]Table of <font color="blue">Contents       </font>these claims may also be asserted <font color="blue">against us</font></td>
    </tr>
    <tr>
      <td>We may incur <font color="blue">significant</font> costs     including payment of <font color="blue">significant</font> damages, in defending or <font color="blue">settling product</font>     <font color="blue">liability</font> claims</td>
    </tr>
    <tr>
      <td>We currently maintain <font color="blue">insurance coverage</font> in the amount of     dlra10  million  for  <font color="blue">product <font color="blue">liability</font></font> claims, <font color="blue">which may prove</font> not to be     sufficient</td>
    </tr>
    <tr>
      <td>Even if a suit is <font color="blue">without merit</font> and <font color="blue">regardless</font> of the outcome,     claims can divert <font color="blue">management</font> time and attention, injure our reputation and     <font color="blue"><font color="blue">adversely</font> affect</font> demand for our <font color="blue"><font color="blue">nanocrystalline</font> materials</font></td>
    </tr>
    <tr>
      <td>We are subject to <font color="blue">governmental <font color="blue">regulations</font></font></td>
    </tr>
    <tr>
      <td>The costs of compliance and     <font color="blue">liability</font> for noncompliance with <font color="blue">governmental <font color="blue">regulations</font></font> could have a     material adverse effect on our business, results of <font color="blue">operations</font> and financial     condition</td>
    </tr>
    <tr>
      <td>Current and future laws and <font color="blue">regulations</font> may require us to make substantial     <font color="blue">expenditures</font> for preventive or remedial action</td>
    </tr>
    <tr>
      <td>Our <font color="blue">operations</font>, business or     assets  may  be  <font color="blue">materially</font>  and  <font color="blue">adversely</font>  affected  <font color="blue">by governmental</font>     <font color="blue">interpretation</font> and <font color="blue">enforcement</font> of current or future environmental, health     and <font color="blue">safety laws</font> and <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>In addition, our coating <font color="blue">operations</font> pose a     risk of <font color="blue"><font color="blue">accident</font>al contamination</font> or injury</td>
    </tr>
    <tr>
      <td>The damages in the event of an     <font color="blue">accident</font> or the costs to prevent or remediate a related <font color="blue">event could exceed</font>     both the amount of our <font color="blue">liability</font> insurance and our resources or otherwise     have a material adverse effect on our business, results of <font color="blue">operations</font> and     <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>In addition, both of our <font color="blue">facilities</font> and all of our <font color="blue">operations</font> are subject to     the plant and laboratory safety <font color="blue">requirement</font>s of <font color="blue">various occupational safety</font>     and <font color="blue">health laws</font></td>
    </tr>
    <tr>
      <td>We believe we have complied in all material <font color="blue">respects with</font>     regard to <font color="blue">governmental <font color="blue">regulations</font></font> applicable to us</td>
    </tr>
    <tr>
      <td>However, we may have to     incur <font color="blue">significant</font> costs in defending or <font color="blue">settling future</font> claims of alleged     violations of <font color="blue">governmental <font color="blue">regulations</font></font> and these <font color="blue">regulations</font> may <font color="blue">materially</font>     restrict or impede our <font color="blue">operations</font> in the future</td>
    </tr>
    <tr>
      <td>In addition, our efforts to     <font color="blue">comply with</font> or contest any <font color="blue">regulatory actions may distract personnel</font> or     <font color="blue">divert resources</font> from other more <font color="blue">important initiatives</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">manufacture</font> and use of <font color="blue">certain products</font> that contain our <font color="blue">nanocrystalline</font>     materials  are subject to extensive <font color="blue">governmental regulation</font>, including     <font color="blue">regulations</font> promulgated by the US Food and Drug Administration, the US     Environmental <font color="blue">Protection </font>Agency and the US Occupational Safety and Health     Administration</td>
    </tr>
    <tr>
      <td>As a result, we are required to adhere to the <font color="blue">requirement</font>s     of the <font color="blue">regulations</font> of <font color="blue">governmental authorities</font> in the <font color="blue">United States </font>and     other countries</td>
    </tr>
    <tr>
      <td>These <font color="blue">regulations</font> could increase our cost of doing business     and may render some <font color="blue">potential markets prohibitively expensive</font></td>
    </tr>
    <tr>
      <td>We have implemented anti-takeover provisions which could discourage or     prevent  a takeover, even if an <font color="blue">acquisition could</font> be <font color="blue">beneficial</font> to our     <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td>In October 1998, we <font color="blue">entered into</font> a <font color="blue">Rights Agreement</font>, <font color="blue">commonly referred</font> to as     a “<font color="blue">poison pill</font></td>
    </tr>
    <tr>
      <td>” The provisions of this <font color="blue">agreement</font> and some of the provisions     of our <font color="blue">certificate</font> of <font color="blue">incorporation</font>, our bylaws and <font color="blue">Delaware </font>law could,     together or <font color="blue">separately</font>:           •   <font color="blue">discourage potential acquisition proposals</font>;           •   delay or prevent a change in control; and           •   limit the price that <font color="blue">investors might</font> be willing to pay in the future     for shares of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>In particular, our board of <font color="blue">directors</font> is authorized to issue up to 24cmam088     shares of <font color="blue">preferred stock</font> (less any <font color="blue">outstanding shares</font> of <font color="blue">preferred stock</font>)     <font color="blue">with rights</font> and privileges that might be senior to our <font color="blue">common stock</font>, without     the consent of the holders of the <font color="blue">common stock</font>, including up to 2cmam500 shares     of <font color="blue">Series A Junior Participating Preferred Stock </font><font color="blue">issuable under</font> the 1998     <font color="blue">Rights Agreement</font></td>
    </tr>
    <tr>
      <td>In addition, Section 203 of the <font color="blue">Delaware </font>General Corporations Law relating     to business <font color="blue">combinations with</font> related <font color="blue">stockholders</font> and the terms of our     <font color="blue">stock option</font> plans relating to changes of control may discourage, delay or     prevent a change in control of our company</td>
    </tr>
    <tr>
      <td>16     ______________________________________________________________________    [17]Table of <font color="blue">Contents       </font>Future sales of our <font color="blue">common stock</font> by existing <font color="blue">stockholders</font> could negatively     affect the <font color="blue">market price</font> of our stock and make it more <font color="blue">difficult</font> for us to     sell stock in the future</td>
    </tr>
    <tr>
      <td>Sales of our <font color="blue">common stock</font> in the <font color="blue">public market</font>, or the <font color="blue">perception</font> that such     <font color="blue">sales could</font> occur, could result in a decline in the <font color="blue">market price</font> of our     <font color="blue">common stock</font> and make it more <font color="blue">difficult</font> for us to complete <font color="blue">future equity</font>     <font color="blue">financings</font></td>
    </tr>
    <tr>
      <td>A substantial number of shares of our <font color="blue">common stock</font> and shares of     <font color="blue">common stock</font> subject to <font color="blue">outstanding warrants</font> and <font color="blue">options may</font> be resold     pursuant to <font color="blue">currently effective registration statements</font></td>
    </tr>
    <tr>
      <td><font color="blue">As of March </font>1,     2006, there are:           •   15cmam828cmam905 shares of <font color="blue">common stock</font> that have been issued in registered     offerings, upon the exercise of <font color="blue">options under</font> our <font color="blue">equity incentive</font> plan or     in <font color="blue"><font color="blue">private placement</font>s</font> and are <font color="blue">freely tradable</font> in the <font color="blue">public market</font>s,           •   1cmam476cmam606 shares of <font color="blue">common stock</font> that may be issued on the exercise of     <font color="blue">stock option</font>s outstanding and <font color="blue">exercisable under</font> our <font color="blue">equity incentive</font> plan;           •   906cmam002 shares of <font color="blue">common stock</font> that were <font color="blue">issued pursuant</font> to our     <font color="blue">September </font>8, 2003 <font color="blue">private placement</font> and the related <font color="blue">warrant which</font> was     <font color="blue">exercised on</font> <font color="blue">September </font>2, 2004</td>
    </tr>
    <tr>
      <td>The resale of these shares has been     registered pursuant to a <font color="blue">Registration Statement </font>on Form S-3 which was     declared <font color="blue">effective by</font> the <font color="blue">Securities and Exchange Commission </font>on August 13,     2004; and           •   1cmam256cmam281 shares of <font color="blue">common stock</font> that were <font color="blue">issued pursuant</font> to our     March 23, 2004 <font color="blue">private placement</font> and may be registered for resale after     March 23, 2006 pursuant the terms of the Registration <font color="blue"><font color="blue">Rights Agreement</font> </font>    executed in <font color="blue">connection with</font> this <font color="blue">private placement</font></td>
    </tr>
    <tr>
      <td>We cannot estimate the number of shares of <font color="blue">common stock</font> that <font color="blue">may actually</font> be     resold in the <font color="blue">public market</font> because this will <font color="blue">depend on</font> the <font color="blue">market price</font> for     our <font color="blue">common stock</font>, the individual <font color="blue">circumstances</font> of the sellers, and other     factors</td>
    </tr>
    <tr>
      <td>If  <font color="blue">stockholders</font>  sell large portions of their holdings in a     <font color="blue">relatively</font> short time, for liquidity or other reasons, the <font color="blue">market price</font> of     our <font color="blue">common stock</font> could decline <font color="blue">significant</font>ly</td>
    </tr>
    <tr>
      <td>Bradford   T  Whitmore  has  <font color="blue">significant</font>  influence  on  all  matters     requiring <font color="blue">stockholder approval</font>  because  he  <font color="blue">beneficial</font>ly owns a large     percentage of our <font color="blue">common stock</font>, and he may vote the <font color="blue">common stock</font> in ways     with which our other <font color="blue">stockholders</font> disagree</td>
    </tr>
    <tr>
      <td><font color="blue">As of March </font>1, 2006, Bradford T Whitmore, <font color="blue">together with</font> his <font color="blue">affiliates</font>,     Grace  Brothers,  Ltd</td>
    </tr>
    <tr>
      <td>and Grace Investments, Ltd, <font color="blue">beneficial</font>ly owned     <font color="blue">approximately</font> 19dtta8prca of the <font color="blue">outstanding shares</font> of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>As a     result, he   has   <font color="blue">significant</font>   influence  on  matters  submitted  to     our <font color="blue">stockholders</font> for approval, including proposals regarding:           •   any merger, <font color="blue">consolidation</font> or sale of all or <font color="blue">substantially</font> all of our     assets;           •   the election of members of our board of <font color="blue">directors</font>; and           •   any <font color="blue">amendment</font> to our <font color="blue">certificate</font> of <font color="blue">incorporation</font></td>
    </tr>
    <tr>
      <td>17     ______________________________________________________________________    [18]Table of <font color="blue">Contents       </font>The <font color="blue">ownership position</font> of Mr</td>
    </tr>
    <tr>
      <td>Whitmore could delay, deter or prevent a     change of control or <font color="blue"><font color="blue">adversely</font> affect</font> the price that <font color="blue">investors might</font> be     willing to pay in the future for shares of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>Whitmore’s     interests may be <font color="blue">significant</font>ly different from the interests of our other     <font color="blue">stockholders</font> and he may vote the <font color="blue">common stock</font> he <font color="blue">beneficial</font>ly owns in ways     with which our other <font color="blue">stockholders</font> disagree</td>
    </tr>
    <tr>
      <td><font color="blue">Investors in the Company </font>should     also note that R Janet Whitmore, one of our <font color="blue">directors</font>, is the sister of     Mr</td>
    </tr>
    <tr>
      <td>We  have  been  involved  in <font color="blue">litigation</font></td>
    </tr>
    <tr>
      <td>If we are involved in similar     <font color="blue">litigation</font> in the future, the expense of defending such <font color="blue">litigation</font> and the     potential  costs  of judgments <font color="blue">against us</font> and the costs of maintaining     <font color="blue">insurance coverage</font> could have a material adverse effect on our financial     performance</td>
    </tr>
    <tr>
      <td>We have <font color="blue">been involved</font> in <font color="blue">three securities</font> class action lawsuits, one of     which was a <font color="blue">consolidation</font> of several related lawsuits</td>
    </tr>
    <tr>
      <td>While all of these     lawsuits have been settled and <font color="blue">dismissed with</font> all <font color="blue">settlements funded by</font> our     <font color="blue">directors</font>  and  officers  <font color="blue">liability</font> insurance, we may be the target of     <font color="blue">additional</font> securities lawsuits in the future</td>
    </tr>
    <tr>
      <td>If we are involved in similar     <font color="blue">litigation</font> in the future, the expense of defending such <font color="blue">litigation</font>, the     <font color="blue">potential costs</font> of judgments <font color="blue">against us</font>, the costs of maintaining insurance     coverage and the diversion of <font color="blue">management</font>’s attention could have a material     adverse effect on our <font color="blue">financial performance</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">stock markets</font> in general, and the <font color="blue">stock prices</font> of <font color="blue">technology</font>-based     companies in particular, have experienced <font color="blue">extreme volatility</font> that often has     <font color="blue">been unrelated</font> to the operating performance of any <font color="blue">specific public company</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">market price</font> of our <font color="blue">common stock</font> has fluctuated in the past and is     likely to fluctuate in the <font color="blue">future as well</font></td>
    </tr>
    <tr>
      <td>Our future <font color="blue">financial performance</font>     and <font color="blue">stock price may</font> be subject to <font color="blue">significant</font> volatility, particularly on a     <font color="blue">quarterly basis</font></td>
    </tr>
    <tr>
      <td><font color="blue">Shortfalls </font>in our revenues in any <font color="blue">given period relative</font> to     the  levels expected by investors could immediately, <font color="blue">significant</font>ly and     <font color="blue"><font color="blue">adversely</font> affect</font> the <font color="blue">trading price</font> of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td><font color="blue">Dilutive Effect of Private Placements</font></td>
    </tr>
    <tr>
      <td>On <font color="blue">September </font>8, 2003 we sold 453cmam001 shares of our <font color="blue">common stock</font> to Grace     Brothers, Ltd</td>
    </tr>
    <tr>
      <td>at a <font color="blue">purchase price</font> of dlra4dtta415 per share <font color="blue">together with</font> a     warrant to purchase a like number of shares of <font color="blue">common stock</font> during the next     twelve  months  also  at a price of dlra4dtta415 per share</td>
    </tr>
    <tr>
      <td>This warrant was     <font color="blue">exercised on</font> <font color="blue">September </font>2, 2004 to acquire 453cmam001 newly issued shares of     <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>The share price for the <font color="blue">common stock</font> was determined <font color="blue">based on</font>     the fifteen-day market closing average for our stock ending <font color="blue">September </font>5,     2003</td>
    </tr>
    <tr>
      <td>On <font color="blue">September </font>8, 2003 and <font color="blue">September </font>2, 2004 the closing sale price of     our <font color="blue">common stock</font> as reported on NASDAQ, was dlra5dtta50 and dlra5dtta49 <font color="blue">respectively</font>,     per share</td>
    </tr>
    <tr>
      <td>On March 23, 2004 we sold 1cmam256cmam281 shares of our <font color="blue">common stock</font> to     Altana at a <font color="blue">purchase price</font> of dlra7dtta96 per share</td>
    </tr>
    <tr>
      <td>On March 23, 2004 the closing     sale price of our <font color="blue">common stock</font>, as reported on NASDAQ, was dlra8dtta26 per share</td>
    </tr>
    <tr>
      <td>Each of these issuances of stock at below the then-current <font color="blue">market price</font> had     a dilutive effect on existing common <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td>We have <font color="blue">never paid dividends</font></td>
    </tr>
    <tr>
      <td>We  <font color="blue">currently intend</font> to retain earnings, if any, to support our growth     strategy</td>
    </tr>
    <tr>
      <td>We  do  not anticipate <font color="blue">paying dividends on</font> our stock in the     <font color="blue">foreseeable future</font></td>
    </tr>
  </tbody>
</table>